The Jury has selected 22 cases for a trial expected to convene on June 6 in St. Louis, Missouri, State Court, wherein the plaintiffs allege that Johnson & Johnson sold them cancer-causing talcum powder.
Imerys SA settled the ovarian cancer claims by these 22 women for at least $5 million. The talc supplier faces 9000 claims stating the asbestos-laden talc supplied to J&J caused mesothelioma and ovarian cancer. This leaves J&J and its consumer-products unit as the only defendant in the case for not warning consumers about the talc cancer risk. However, Imerys maintains a firm denial regarding the presence of cancer-causing agents in the talcum powder. Thousands of lawsuits filed all over the nation allege the baby powder use for feminine hygiene purpose led to ovarian cancer in several women; many have concluded in multimillion verdicts against the talc manufacturer.
Similar lawsuits filed against J&J in state courts in California, New Jersey, and Delaware are consolidated for pre-trial proceedings in the U.S. District Court for the District of New Jersey MDL No. 2738 (In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices, and Products Liability Litigation), presided over by Hon. Freda L. Wolfson, U.S.D.J./ Hon. Lois H. Goodman, U.S.M.J.